Cargando…
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture–Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18–65 Years in 2019–2020
BACKGROUND: Emerging data suggest that second-generation influenza vaccines with higher hemagglutinin (HA) antigen content and/or different production methods may induce stronger antibody responses to HA than standard-dose egg-based influenza vaccines in adults. We compared antibody responses to hig...
Autores principales: | Naleway, Allison L, Kim, Sara S, Flannery, Brendan, Levine, Min Z, Murthy, Kempapura, Sambhara, Suryaprakash, Gangappa, Shivaprakash, Edwards, Laura J, Ball, Sarah, Grant, Lauren, Zunie, Tnelda, Cao, Weiping, Gross, F Liaini, Groom, Holly, Fry, Alicia M, Hunt, Danielle, Jeddy, Zuha, Mishina, Margarita, Wesley, Meredith G, Spencer, Sarah, Thompson, Mark G, Gaglani, Manjusha, Dawood, Fatimah S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249269/ https://www.ncbi.nlm.nih.gov/pubmed/37305842 http://dx.doi.org/10.1093/ofid/ofad223 |
Ejemplares similares
-
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial
por: Gaglani, Manjusha, et al.
Publicado: (2022) -
Consistency of self‐reported and documented historical influenza vaccination status of US healthcare workers
por: Regan, Annette K., et al.
Publicado: (2022) -
A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose
por: Sayedahmed, Ekramy E., et al.
Publicado: (2018) -
Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI(®) induces enhanced serological, cellular and protective immune responses
por: Cao, Weiping, et al.
Publicado: (2018) -
Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses
por: Hassan, Ahmed O., et al.
Publicado: (2017)